Current Affairs

Adding Radioligand to Enzalutamide Boosts OS in Metastatic CRPC

Photo of News Fetcher News FetcherFebruary 14, 2025
0 67 Less than a minute
Adding Radioligand to Enzalutamide Boosts OS in Metastatic CRPC

(MedPage Today)-San Francisco-adding radioactive offices with 177LU-Psma-617 (Pluvicto) to Enzalutamide (XTANDI). It is overall survival (OS) in patients with prostate cancer resistant to metastatic (CRPC). ..

Photo of News Fetcher News FetcherFebruary 14, 2025
0 67 Less than a minute
Photo of News Fetcher

News Fetcher

Related Articles

YES, PLEASE: Joy Reid Calls Jasmine Crockett the Leader of the Democrats, and Republicans Rejoice

YES, PLEASE: Joy Reid Calls Jasmine Crockett the Leader of the Democrats, and Republicans Rejoice

2 weeks ago
Houthis in Yemen Won’t Be Defeated by Airstrikes Alone, Experts Say

Houthis in Yemen Won’t Be Defeated by Airstrikes Alone, Experts Say

March 27, 2025
Trump takes aim at Bruce Springsteen, Taylor Swift on social media

Trump takes aim at Bruce Springsteen, Taylor Swift on social media

May 17, 2025
Trump’s tariffs regime aims for much worse than a global trade war

Trump’s tariffs regime aims for much worse than a global trade war

April 4, 2025

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button